Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous Sodium Chloride for Neurological Condition (Sweden Phase 4)
2018-003868-32Phase 4Terminated
- Sponsor
- University of Gothenburg
- Start
- Dec 2018
- Countries
- 1
01
Overview
Phase 4 trial of sodium chloride in neurological diseases, sponsored by University of Gothenburg. Started Dec 2018; status: terminated.
02
Drugs
sodium chloride
03
Conditions
neurological diseases
Beyond the preview
Go deeper on 2018-003868-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-003868-32.